Advertisement
Screener

NUTRIBAND INC. (NTRB) Overview

NUTRIBAND INC. (NTRB) Overview

  • 1 May 2026: Period ending 31 Jul 2026; Estimate (m); Actual -0.07; Beat / miss (m).
  • 1 Feb 2026: Period ending 30 Apr 2026; Estimate (m); Actual -0.10; Beat / miss (m).
  • 1 Aug 2025: Period ending 31 Oct 2025; Estimate (m); Actual -0.32; Beat / miss (m).
  • 1 May 2025: Period ending 31 Jul 2025; Estimate (m); Actual -2.12; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$2.67$3.44$4.42$5.70$7.33$9.442025-09-292026-09-29$1.83$2.64$3.79$5.45$7.83$11.262021-10-012026-09-29$1.83$2.64$3.79$5.45$7.83$11.262021-10-012026-09-29$1.83$2.64$3.79$5.45$7.83$11.262021-10-012026-09-29$1.83$2.64$3.79$5.45$7.83$11.262021-10-012026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$8.25
Previous close
$8.23
Change
$0.02
Change (%)
0.24%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

NTRB
+81.72%
S&P 500
(m)

1 year

NTRB
+16.86%
S&P 500
(m)

3 years

NTRB
+223.53%
S&P 500
(m)

5 years

NTRB
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Jul 2026 ○ Estimate (m) ● Actual -0.07

-2.20-1.62-1.05-0.470.1130 Apr 2025: estimate (m); actual -0.1230 Apr 2025(m)31 Jul 2025: estimate (m); actual -2.1231 Jul 2025(m)31 Oct 2025: estimate (m); actual -0.3231 Oct 2025(m)30 Apr 2026: estimate (m); actual -0.1030 Apr 2026(m)31 Jul 2026: estimate (m); actual -0.0731 Jul 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 May 202631 Jul 2026(m)-0.07(m)(m)
1 Feb 202630 Apr 2026(m)-0.10(m)(m)
1 Aug 202531 Oct 2025(m)-0.32(m)(m)
1 May 202531 Jul 2025(m)-2.12(m)(m)
1 Feb 202530 Apr 2025(m)-0.12(m)(m)

31 Jan 2026 ○ Estimate (m) ● Actual -2.58

-2.66-2.08-1.51-0.93-0.3531 Jan 2022: estimate (m); actual -0.8031 Jan 2022(m)31 Jan 2023: estimate (m); actual -0.5331 Jan 2023(m)31 Jan 2024: estimate (m); actual -0.6931 Jan 2024(m)31 Jan 2025: estimate (m); actual -0.9931 Jan 2025(m)31 Jan 2026: estimate (m); actual -2.5831 Jan 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Feb 202531 Jan 2026(m)-2.58(m)(m)
1 Feb 202431 Jan 2025(m)-0.99(m)(m)
1 Feb 202331 Jan 2024(m)-0.69(m)(m)
1 Feb 202231 Jan 2023(m)-0.53(m)(m)
1 Feb 202131 Jan 2022(m)-0.80(m)(m)

Revenue vs. Earnings

USD

31 Jul 2026 ■ Revenue 0.44M ■ Earnings -0.88M — Profit margin -201.26%

-4.39M-1120.0%-2.61M-813.4%-0.83M-506.8%0.95M-200.3%31 Oct 2025: revenue 0.35M; earnings -3.87M; profit margin -1118.99%31 Oct 202531 Jan 2026: revenue 0.40M*; earnings -0.97M*; profit margin -241.59%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-11-01 to 2026-01-31; USD.31 Jan 202630 Apr 2026: revenue 0.43M; earnings -1.24M; profit margin -286.56%30 Apr 202631 Jul 2026: revenue 0.44M; earnings -0.88M; profit margin -201.26%31 Jul 2026

31 Jan 2026 ■ Revenue 2.04M ■ Earnings -8.23M — Profit margin -404.08%

-12.00M-490.9%-6.78M-398.8%-1.56M-306.7%3.65M-214.6%31 Jan 2023: revenue 2.08M; earnings -4.48M; profit margin -215.59%31 Jan 202331 Jan 2024: revenue 2.09M; earnings -5.49M; profit margin -263.04%31 Jan 202431 Jan 2025: revenue 2.14M; earnings -10.48M; profit margin -489.95%31 Jan 202531 Jan 2026: revenue 2.04M; earnings -8.23M; profit margin -404.08%31 Jan 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$8.25(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$8.25High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning NTRB

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Jul 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-6.96M
Profit margin
-430.43%
Return on assets · 12 month
-84.55%
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
143.96K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
22.04%*
Total return · month
84.98%*
Total return · quarter
157.01%*
Total return · half year
113.73%*
Total return · year to date
81.72%*
Total return · 1 year
16.86%*
Total return · 3 years
223.53%*
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$1.62M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

NUTRIBAND INC. Overview

View more →

(m)

(m)

SEC CIK
1676047
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
121 S. ORANGE AVE., SUITE 1500, ORLANDO, Florida, 32801, United States
Fiscal year end
0131
Phone
407 377-6695

Similar stocks

Stock NameCountryMarket CapPE Ratio
Conexeu Sciences Inc. (CNXU)United States$0.111B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
Inogen Inc (INGN)United States$0.139B-7.00
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B